Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells
Parkinson’s Disease (PD) is an intractable disease resulting in localized neurodegeneration of dopaminergic neurons of the substantia nigra pars compacta. Many current therapies of PD can only address the symptoms and not the underlying neurodegeneration of PD. To better understand the pat...
Main Authors: | Theo Stoddard-Bennett, Renee Reijo Pera |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4409/8/1/26 |
Similar Items
-
Stem cell therapy for Parkinson’s disease: safety and modeling
by: Theo Stoddard-Bennett, et al.
Published: (2020-01-01) -
Alpha‐synuclein dynamics in induced pluripotent stem cell‐derived dopaminergic neurons from a Parkinson’s disease patient (PARK4) with SNCA triplication
by: Hayato Fukusumi, et al.
Published: (2021-02-01) -
Patient-Specific Induced Pluripotent Stem Cell Models of Parkinson’s Disease
by: Liao, Mei-Chih
Published: (2014) -
Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells
by: Douglas A. Grow, et al.
Published: (2016-09-01) -
Roles of stem cells in the treatment of Parkinson's disease
by: Yasaman Ebrahimikia, et al.
Published: (2018-10-01)